How value-based contracts in Medicaid can promote opioid addiction recovery
Fierce Healthcare - Industry Voices
Feburary 19, 2020
by Gus Crothers, M.D., national medical director of Groups Recover Together
Vermont’s Medicaid program recently saw its spending on urine toxicology testing rise six-fold in three years, reaching $15 million dollars in 2018.
On the surface, this rise in spending reflects a positive trend: more patients are receiving life-saving treatment for opioid use disorder. But, does all this testing truly help the patient? Does frequent laboratory toxicology testing promote recovery?